{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T01:02:04Z","timestamp":1793840524010,"version":"4.6.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:00:00Z","timestamp":1715817600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-023795"],"award-info":[{"award-number":["INV-023795"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ajog.2024.05.012","type":"journal-article","created":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T13:23:40Z","timestamp":1715952220000},"page":"228.e1-228.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Optimization of the betamethasone and dexamethasone dosing regimen during pregnancy: a combined placenta perfusion and pregnancy physiologically based pharmacokinetic modeling approach"],"prefix":"10.1016","volume":"232","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3584-2318","authenticated-orcid":false,"given":"Joyce E.M.","family":"Van Der Heijden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3211-2862","authenticated-orcid":false,"given":"Hedwig","family":"Van Hove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niki M.","family":"Van Elst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Van Den Broek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4592-4288","authenticated-orcid":false,"given":"Joris","family":"Van Drongelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9215-5795","authenticated-orcid":false,"given":"Hubertina C.J.","family":"Scheepers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0502-0647","authenticated-orcid":false,"given":"Saskia N.","family":"De Wildt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2599-7540","authenticated-orcid":false,"given":"Rick","family":"Greupink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2024.05.012_bib1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1891\/0730-0832.37.3.169","article-title":"Prevention and treatment of respiratory distress syndrome in preterm neonates","volume":"37","author":"McPherson","year":"2018","journal-title":"Neonatal Netw"},{"key":"10.1016\/j.ajog.2024.05.012_bib2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1542\/peds.2013-3442","article-title":"Respiratory support in preterm infants at birth","volume":"133","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajog.2024.05.012_bib3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/archdischild-2014-306642","article-title":"The management of neonatal respiratory distress syndrome in preterm infants (European Consensus Guidelines--2013 update)","volume":"100","author":"Sakonidou","year":"2015","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"10.1016\/j.ajog.2024.05.012_bib4","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1055\/s-0028-1085066","article-title":"The probability of neonatal respiratory distress syndrome as a function of gestational age and lecithin\/sphingomyelin ratio","volume":"25","author":"St Clair","year":"2008","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajog.2024.05.012_bib5","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1542\/peds.50.4.515","article-title":"A\u00a0controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants","volume":"50","author":"Liggins","year":"1972","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajog.2024.05.012_bib6","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/0002-9378(95)90210-4","article-title":"Scientific basis and therapeutic regimens for use of antenatal glucocorticoids","volume":"173","author":"Ballard","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.05.012_bib7","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1097\/AOG.0000000000002237","article-title":"Committee Opinion No. 713: antenatal corticosteroid therapy for fetal maturation","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.05.012_bib8","series-title":"Antenatal corticosteroids given to women prior to birth to improve fetal, infant, child and adult health","year":"2015"},{"key":"10.1016\/j.ajog.2024.05.012_bib9","series-title":"Preterm labour and birth (QS135)","year":"2019"},{"key":"10.1016\/j.ajog.2024.05.012_bib10","series-title":"WHO recommendations on antenatal corticosteroids for improving preterm birth outcomes","year":"2022"},{"key":"10.1016\/j.ajog.2024.05.012_bib12","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.ajog.2022.07.030","article-title":"The complex challenge of antenatal steroid therapy nonresponsiveness","volume":"227","author":"Takahashi","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.05.012_bib13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.steroids.2016.05.012","article-title":"Effects of antenatal glucocorticoids on the developing brain","volume":"114","author":"Carson","year":"2016","journal-title":"Steroids"},{"key":"10.1016\/j.ajog.2024.05.012_bib14","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jpeds.2019.09.015","article-title":"Antenatal corticosteroids-a concern for lifelong outcomes","volume":"217","author":"Jobe","year":"2020","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.ajog.2024.05.012_bib15","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1542\/peds.68.5.638","article-title":"Cognitive and psychosocial development of 4-year-old children whose mothers were treated antenatally with betamethasone","volume":"68","author":"MacArthur","year":"1981","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajog.2024.05.012_bib16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1542\/peds.70.1.99","article-title":"School progress and cognitive development of 6-year-old children whose mothers were treated antenatally with betamethasone","volume":"70","author":"MacArthur","year":"1982","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajog.2024.05.012_bib17","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/bmj.38576.494363.E0","article-title":"Antenatal exposure to betamethasone: psychological functioning and health related quality of life 31 years after inclusion in randomised controlled trial","volume":"331","author":"Dalziel","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2024.05.012_bib18","article-title":"Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth","volume":"12","author":"McGoldrick","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2024.05.012_bib19","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2022.0483","article-title":"Evaluation of long-term outcomes associated with preterm exposure to antenatal corticosteroids: a systematic review and meta-analysis","volume":"176","author":"Ninan","year":"2022","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.ajog.2024.05.012_bib20","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1001\/jama.2020.3937","article-title":"Associations between maternal antenatal corticosteroid treatment and mental and behavioral disorders in children","volume":"323","author":"R\u00e4ikk\u00f6nen","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2024.05.012_bib21","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1017\/S0033291718004129","article-title":"Associations of antenatal glucocorticoid exposure with mental health in children","volume":"50","author":"Wolford","year":"2020","journal-title":"Psychol Med"},{"key":"10.1016\/j.ajog.2024.05.012_bib22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jpeds.2022.09.050","article-title":"Antenatal corticosteroid exposure is associated with childhood mental disorders in late preterm and term infants","volume":"253","author":"Lin","year":"2023","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.ajog.2024.05.012_bib23","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41390-020-01249-w","article-title":"Antenatal corticosteroids: a reappraisal of the drug formulation and dose","volume":"89","author":"Jobe","year":"2021","journal-title":"Pediatr Res"},{"key":"10.1016\/j.ajog.2024.05.012_bib24","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/cpt.1887","article-title":"Maternal betamethasone for prevention of respiratory distress syndrome in neonates: population pharmacokinetic and pharmacodynamic approach","volume":"108","author":"Foissac","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ajog.2024.05.012_bib25","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.siny.2019.05.003","article-title":"Optimizing antenatal corticosteroid therapy","volume":"24","author":"Kemp","year":"2019","journal-title":"Semin Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2024.05.012_bib26","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0140-6736(22)01535-5","article-title":"Neonatal outcomes for women at risk of preterm delivery given half dose versus full dose of antenatal betamethasone: a randomised, multicentre, double-blind, placebo-controlled, non-inferiority trial","volume":"400","author":"Schmitz","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2024.05.012_bib27","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0002-9378(80)90855-8","article-title":"Results of a double-blind controlled study on the use of betamethasone in the prevention of respiratory distress syndrome","volume":"136","author":"Doran","year":"1980","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.05.012_bib28","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1471-0528.1989.tb02413.x","article-title":"Antenatal administration of betamethasone to prevent respiratory distress syndrome in preterm infants: report of a UK multicentre trial","volume":"96","author":"Gamsu","year":"1989","journal-title":"Br J Obstet Gynaecol"},{"issue":"2","key":"10.1016\/j.ajog.2024.05.012_bib29","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/psp4.12274","article-title":"Drug dosing in pregnant women: challenges and opportunities in using physiologically based pharmacokinetic modeling and simulations","volume":"7","author":"Ke","year":"2018","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10.1016\/j.ajog.2024.05.012_bib30","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10928-020-09698-w","article-title":"Drug dosing during pregnancy\u2014opportunities for physiologically based pharmacokinetic models","volume":"47","author":"Abduljalil","year":"2020","journal-title":"J\u00a0Pharmacokinet Pharmacodyn"},{"key":"10.1016\/j.ajog.2024.05.012_bib31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.xphs.2018.10.033","article-title":"Physiologically based pharmacokinetic modeling in regulatory science: an update from the U.S. Food and Drug Administration's Office of Clinical Pharmacology","volume":"108","author":"Grimstein","year":"2019","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.ajog.2024.05.012_bib32","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/cpt.1438","article-title":"Evaluation of maternal drug exposure following the administration of antenatal corticosteroids during late pregnancy using physiologically-based pharmacokinetic modeling","volume":"106","author":"Ke","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ajog.2024.05.012_bib33","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/psp4.12899","article-title":"Minimal physiologically-based hybrid model of pharmacokinetics in pregnant women: application to antenatal corticosteroids","volume":"12","author":"Krzyzanski","year":"2023","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10.1016\/j.ajog.2024.05.012_bib34","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/psp4.12674","article-title":"Estimating fetal exposure to the P-gp substrates, corticosteroids, by PBPK modeling to inform prevention of neonatal respiratory distress syndrome","volume":"10","author":"Anoshchenko","year":"2021","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10.1016\/j.ajog.2024.05.012_bib35","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1002\/cpt.1748","article-title":"Assessment of maternal and fetal dolutegravir exposure by integrating ex\u00a0vivo placental perfusion data and physiologically-based pharmacokinetic modeling","volume":"107","author":"Freriksen","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ajog.2024.05.012_bib36","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s40262-022-01127-0","article-title":"Prediction of maternal and fetal doravirine exposure by integrating physiologically based pharmacokinetic modeling and human placenta perfusion experiments","volume":"61","author":"Bukkems","year":"2022","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ajog.2024.05.012_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2022.105471","article-title":"Predicting fetal exposure of crizotinib during pregnancy: combining human ex\u00a0vivo placenta perfusion data with physiologically-based pharmacokinetic modeling","volume":"85","author":"Roelofsen","year":"2022","journal-title":"Toxicol In\u00a0Vitro"},{"key":"10.1016\/j.ajog.2024.05.012_bib38","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2165\/11597440-000000000-00000","article-title":"Anatomical, physiological and metabolic changes with gestational age during normal pregnancy: a database for parameters required in physiologically based pharmacokinetic modelling","volume":"51","author":"Abduljalil","year":"2012","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ajog.2024.05.012_bib39","doi-asserted-by":"crossref","first-page":"132.e1","DOI":"10.1016\/j.ajog.2017.11.560","article-title":"Low-dose betamethasone-acetate for fetal lung maturation in preterm sheep","volume":"218","author":"Schmidt","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.05.012_bib40","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0002-9378(16)32633-3","article-title":"Effect of antenatal dexamethasone administration on the prevention of respiratory distress syndrome","volume":"141","year":"1981","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.05.012_bib41","doi-asserted-by":"crossref","first-page":"254.e1-12","DOI":"10.1016\/j.ajog.2010.06.029","article-title":"Betamethasone in pregnancy: influence of maternal body weight and multiple gestation on pharmacokinetics","volume":"203","author":"Della Torre","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.05.012_bib42","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jogc.2022.02.071","article-title":"Single dose of antenatal corticosteroids (SNACS) non-inferiority randomized controlled trial for pregnancies at risk of preterm delivery","volume":"44","author":"McDonald","year":"2022","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.ajog.2024.05.012_bib44","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1542\/peds.63.1.64","article-title":"Risk of respiratory distress syndrome after prenatal dexamethasone treatment","volume":"63","author":"Taeusch","year":"1979","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajog.2024.05.012_bib45","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/0029-7844(96)00033-6","article-title":"Randomized trial of antenatal dexamethasone in surfactant-treated infants delivered before 30 weeks' gestation","volume":"87","author":"Silver","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.05.012_bib46","doi-asserted-by":"crossref","first-page":"186.e1","DOI":"10.1016\/j.ajog.2009.09.033","article-title":"Dose-response effects of betamethasone on maturation of the fetal sheep lung","volume":"202","author":"Loehle","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.05.012_bib47","doi-asserted-by":"crossref","first-page":"903.e1","DOI":"10.1016\/j.ajog.2022.06.058","article-title":"Low-dose antenatal betamethasone treatment achieves preterm lung maturation equivalent to that of the World Health Organization dexamethasone regimen but with reduced endocrine disruption in a sheep model of pregnancy","volume":"227","author":"Usuda","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.05.012_bib48","doi-asserted-by":"crossref","first-page":"301.e1","DOI":"10.1016\/j.ajog.2018.05.007","article-title":"The efficacy of antenatal steroid therapy is dependent on the duration of low-concentration fetal exposure: evidence from a sheep model of pregnancy","volume":"219","author":"Kemp","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.05.012_bib49","doi-asserted-by":"crossref","first-page":"L628","DOI":"10.1152\/ajplung.00139.2023","article-title":"Respiratory benefit in preterm lambs is progressively lost when the concentration of fetal plasma betamethasone is titrated below two nanograms per milliliter","volume":"325","author":"Fee","year":"2023","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.ajog.2024.05.012_bib50","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.placenta.2006.11.002","article-title":"Animal models of human placentation--a review","volume":"28 Suppl A","author":"Carter","year":"2007","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2024.05.012_bib51","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1677\/joe.0.0450515","article-title":"Premature delivery of foetal lambs infused with glucocorticoids","volume":"45","author":"Liggins","year":"1969","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.ajog.2024.05.012_bib52","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1056\/NEJMoa2022398","article-title":"Antenatal dexamethasone for early preterm birth in low-resource countries","volume":"383","author":"Oladapo","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2024.05.012_bib53","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/MLR.0b013e3182408812","article-title":"Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact","volume":"50","author":"Curran","year":"2012","journal-title":"Med Care"},{"key":"10.1016\/j.ajog.2024.05.012_bib54","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1017\/cts.2020.19","article-title":"The role of data and safety monitoring boards in implementation trials: when are they justified?","volume":"4","author":"Fiscella","year":"2020","journal-title":"J\u00a0Clin Transl Sci"},{"key":"10.1016\/j.ajog.2024.05.012_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101916","article-title":"Effect of antenatal corticosteroid administration-to-birth interval on maternal and newborn outcomes: a systematic review","volume":"58","author":"McDougall","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ajog.2024.05.012_bib56","article-title":"Effect of dexamethasone on newborn survival at different administration-to-birth intervals: a secondary analysis of the WHO ACTION (Antenatal CorticosTeroids for Improving Outcomes in Preterm Newborn)-I trial","volume":"53","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ajog.2024.05.012_bib57","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1080\/10641955.2016.1190846","article-title":"Preeclampsia and preterm delivery: a population-based case-control study","volume":"35","author":"Davies","year":"2016","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2024.05.012_bib58","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.preghy.2012.01.001","article-title":"The placenta in preeclampsia","volume":"2","author":"Roberts","year":"2012","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajog.2024.05.012_bib59","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1124\/dmd.111.038166","article-title":"ATP-binding cassette transporter expression in human placenta as a function of pregnancy condition","volume":"39","author":"Mason","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.ajog.2024.05.012_bib60","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1159\/000487100","article-title":"Chorioamnionitis induces a specific signature of placental ABC transporters associated with an increase of miR-331-5p in the human preterm placenta","volume":"45","author":"do Imperio","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.ajog.2024.05.012_bib61","doi-asserted-by":"crossref","first-page":"447.e17","DOI":"10.1016\/j.ajog.2012.02.016","article-title":"The impact of drug metabolizing enzyme polymorphisms on outcomes after antenatal corticosteroid use","volume":"206","author":"Haas","year":"2012","journal-title":"Am J Obstet Gynecol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937824005945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937824005945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T19:16:36Z","timestamp":1786216596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937824005945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0002937824005945"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2024.05.012","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimization of the betamethasone and dexamethasone dosing regimen during pregnancy: a combined placenta perfusion and pregnancy physiologically based pharmacokinetic modeling approach","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2024.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}